UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 287

Sortiert nach

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

The lancet oncology, 2019-04, Vol.20 (4), p.518-530

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study

Journal of clinical oncology, 2018-02, Vol.36 (6), p.536-542

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical and biomarker predictors of side effects from tamoxifen

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.1107-1118

2012

Link zum Volltext

Verfügbarkeit prüfen

Family Communication of BRCA1/2 Results and Family Uptake of BRCA1/2 Testing in a Diverse Population of BRCA1/2 Carriers

Journal of genetic counseling, 2013-10, Vol.22 (5), p.603-612

2013

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and Type of BRCA Mutations in Hispanics Undergoing Genetic Cancer Risk Assessment in the Southwestern United States: A Report From the Clinical Cancer Genetics Community Research Network

Journal of clinical oncology, 2013-01, Vol.31 (2), p.210-216

2013

Link zum Volltext

Verfügbarkeit prüfen

Communication of BRCA Results and Family Testing in 1,103 High-Risk Women

Cancer epidemiology, biomarkers & prevention, 2010-09, Vol.19 (9), p.2211-2219

2010

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Methods to Measure Low Serum Estradiol Levels in Postmenopausal Women

The journal of clinical endocrinology and metabolism, 2006-10, Vol.91 (10), p.3791-3797

2006

Link zum Volltext

Verfügbarkeit prüfen

Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers: Role of Serial Sectioning in the Detection of Occult Malignancy

Journal of clinical oncology, 2005-01, Vol.23 (1), p.127-132

2005

Link zum Volltext

Verfügbarkeit prüfen

Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling

Genetics in medicine, 2011-12, Vol.13 (12), p.1045-1050

2011

Link zum Volltext

Verfügbarkeit prüfen

A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome

Hereditary cancer in clinical practice, 2012-04, Vol.10 (1), p.4-4, Article 4

2012

Link zum Volltext

Verfügbarkeit prüfen

The potential of alkaloids in drug discovery

Phytotherapy research, 2001-05, Vol.15 (3), p.183-205

2001

Link zum Volltext

Verfügbarkeit prüfen

Fecal Incontinence in Females Older Than Aged 40 Years: Who is at Risk?

Diseases of the colon & rectum, 2006-06, Vol.49 (6), p.841-851

2006

Link zum Volltext

Verfügbarkeit prüfen

Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing

JAMA internal medicine, 2013-01, Vol.173 (2), p.96

2013

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the First-Year Data from an HPV Vaccination Van Program in South Carolina, U.S

Journal of clinical medicine, 2023-02, Vol.12 (4), p.1362

2023

Link zum Volltext

Verfügbarkeit prüfen

Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers

Genetic testing and molecular biomarkers, 2009-02, Vol.13 (1), p.51

2009

Link zum Volltext

Verfügbarkeit prüfen

Genetic counseling, cancer screening, breast cancer characteristics, and general health among a diverse population of BRCA genetic testers

Journal of health care for the poor and underserved, 2013-08, Vol.24 (3), p.1150-1166

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment

Genome medicine, 2011-10, Vol.3 (10), p.64-64

2011

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and temporal trends in patient registries: focus on the life sciences industry, 1981-2012

Pharmacoepidemiology and drug safety, 2015-04, Vol.24 (4), p.389-398

2015

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations

Familial cancer, 2009-06, Vol.8 (2), p.153-158

2009

Link zum Volltext

Verfügbarkeit prüfen

Association of statin use and development and progression of hip osteoarthritis in elderly women

Journal of rheumatology, 2005-01, Vol.32 (1), p.106

2005

Link zum Volltext

Verfügbarkeit prüfen

Narratives in the making: teaching and learning at Corktown Community High School

Narratives in the making, 2004

Beattie, Mary

1, 2004

Link zum Volltext

Verfügbarkeit prüfen

Endogenous Sex Hormones, Breast Cancer Risk, and Tamoxifen Response: An Ancillary Study in the NSABP Breast Cancer Prevention Trial (P-1)

JNCI : Journal of the National Cancer Institute, 2006-01, Vol.98 (2), p.110-115

2006

Link zum Volltext

Verfügbarkeit prüfen

Sterol Structure Determines Miscibility versus Melting Transitions in Lipid Vesicles

Biophysical journal, 2005-09, Vol.89 (3), p.1760-1768

2005

Link zum Volltext

Verfügbarkeit prüfen

NatHER: protocol for systematic evaluation of trends in survival among patients with HER2-positive advanced breast cancer

Systematic reviews, 2015-10, Vol.4 (1), p.133-133, Article 133

2015

Link zum Volltext

Verfügbarkeit prüfen

Classifying Variants of Undetermined Significance in BRCA2 with Protein Likelihood Ratios

Cancer informatics, 2008-01, Vol.2008 (1), p.203-216

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 287

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(210)
Mit Volltextzugriff
(265)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(285)
Japanisch
(22)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study

Clinical and biomarker predictors of side effects from tamoxifen

Family Communication of BRCA1/2 Results and Family Uptake of BRCA1/2 Testing in a Diverse Population of BRCA1/2 Carriers

Prevalence and Type of BRCA Mutations in Hispanics Undergoing Genetic Cancer Risk Assessment in the Southwestern United States: A Report From the Clinical Cancer Genetics Community Research Network

Communication of BRCA Results and Family Testing in 1,103 High-Risk Women

Comparison of Methods to Measure Low Serum Estradiol Levels in Postmenopausal Women

Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers: Role of Serial Sectioning in the Detection of Occult Malignancy

Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling

A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome

The potential of alkaloids in drug discovery

Fecal Incontinence in Females Older Than Aged 40 Years: Who is at Risk?

Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing

Evaluation of the First-Year Data from an HPV Vaccination Van Program in South Carolina, U.S

Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers

Genetic counseling, cancer screening, breast cancer characteristics, and general health among a diverse population of BRCA genetic testers

Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment

Characteristics and temporal trends in patient registries: focus on the life sciences industry, 1981-2012

Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations

Association of statin use and development and progression of hip osteoarthritis in elderly women

Narratives in the making: teaching and learning at Corktown Community High School

Endogenous Sex Hormones, Breast Cancer Risk, and Tamoxifen Response: An Ancillary Study in the NSABP Breast Cancer Prevention Trial (P-1)

Sterol Structure Determines Miscibility versus Melting Transitions in Lipid Vesicles

NatHER: protocol for systematic evaluation of trends in survival among patients with HER2-positive advanced breast cancer

Classifying Variants of Undetermined Significance in BRCA2 with Protein Likelihood Ratios

Suchergebnisse filtern